Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Clinical Data

Pivotal trial of Moderna’s H5N1 bird flu jab gets underway

 April 22, 2026

Pharmaphorum

The first volunteers in a large-scale trial of Moderna’s mRNA-based vaccine against bird flu have received shots in the UK and US.

Clinical DataInfectious DiseaseRead full story

Post navigation

BioAegis and Prenosis partner for inflammatory disease therapies →
← New data build case for Roche’s oral BTK drug for MS

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com